-
Yangtze River Pharmaceutical Group’s Innovative Anti-insomnia Drug Fazamorexant Debut at the World Sleep Congress 2025
22 Sep 2025 03:00 GMT
… first-class innovative anti-insomnia drug independently developed by … Group’s Innovative Anti-insomnia Drug Fazamorexant Debut at … Group’s Innovative Anti-insomnia Drug Fazamorexant Debut at … Group’s Innovative Anti-insomnia Drug Fazamorexant Debut at …
-
Insomnia Treatment Restructured
17 Sep 2025 03:45 GMT
… -morning impairment after use of insomnia drugs; FDA requires lower recommended doses …
-
Neurim Pharma's Slenyto receives Health Canada's marketing nod to treat insomnia in children and adolescents with autism spectrum disorder
12 Sep 2025 11:00 GMT
Neurim Pharmaceuticals, a neuroscience drug discovery and development company, announced that Health Canada has granted marketing authorization for Slenyto, an extended-release melatonin minitablet indicated for the treatment of insomnia in children and …
-
<![CDATA[Dual Orexin Receptor Agonists Show Lower Real-World Abuse Potential Than Traditional Insomnia Treatments]]>
11 Sep 2025 10:12 GMT
… compared with other drugs for insomnia treatment. This observation included schedule IV … potential of DORA class for insomnia treatment at WSC 2025. News release … -potential-of-DORA-class-for-insomnia-treatment-at-WSC-2025.html
2 …
-
Idorsia highlights very low real-world abuse potential of DORA class for insomnia treatment at WSC 2025
08 Sep 2025 15:45 GMT
… compared with other drugs for insomnia treatment. This observation included schedule IV … ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize …
-
Can BrainEcho Technology Help Treat Insomnia?
04 Sep 2025 20:12 GMT
… post Can BrainEcho Technology Help Treat Insomnia? appeared first on San Diego …
-
New anti-insomnia therapy impresses intl experts – China Daily
14 Sep 2025 13:54 GMT
… that Quviviq, a new-generation anti-insomnia therapy developed in collaboration with … the development of medications to treat insomnia,” he said.
Laura Palagini, a … demand for safe and effective insomnia treatments in clinical practice. We hope …
-
Seltorexant Outperforms Placebo, Standard Insomnia Treatment
26 Aug 2025 10:46 GMT
… placebo and zolpidem, a standard insomnia treatment, showed a new study. Treatment …
-
Japan's Eisai launches in-house developed anti-insomnia drug DAYVIGO(R) (Lemborexant) in China
18 Aug 2025 08:52 GMT
… Eisai launches in-house developed anti-insomnia drug DAYVIGO(R) (Lemborexant) in China …
-
Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) In China
18 Aug 2025 03:14 GMT
… ) Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China …